A New Approach to Finding Type 1 Diabetes Early: Testing During Routine Checkups

Type 1 diabetes develops when the immune system mistakenly attacks the cells in the pancreas that produce insulin. Before symptoms appear, the body produces autoantibodies—proteins that signal this immune attack is underway. Testing for these autoantibodies can identify people at risk long before they experience symptoms like extreme thirst or fatigue.

Catching Type 1 diabetes early, before significant damage occurs, offers a window of opportunity to potentially improve health outcomes. However, most children are not routinely screened for these warning signs, even though simple blood tests can detect them.

Researchers at Geisinger, a large health system, examined how often Type 1 diabetes autoantibody screening actually occurs in routine pediatric practice. Looking at records from 2022, they found that among over 312,000 pediatric patients in their system, only 9 had undergone autoantibody testing as part of screening. This striking finding revealed how rare such screening is in everyday clinical care.

This gap exists partly because screening for Type 1 diabetes is not yet standard practice. Families typically learn about screening through specialty programs rather than during routine checkups with their primary care doctor.

To address this gap, researchers developed an 'opportunistic screening' approach. The idea is straightforward: when a child comes in for a regular well-child visit and has routine blood work done, the same sample can be tested for Type 1 diabetes autoantibodies—no extra needle stick required.

Between March and April 2024, researchers piloted this approach at a pediatric primary care clinic. Of 120 eligible patients, 31 enrolled in the program and 19 completed the screening test. While 16% completion is modest, it represents children who would likely never have been screened otherwise.

The pilot revealed both the promise and the challenges of integrating Type 1 diabetes screening into routine pediatric care. Interviews with staff and families identified specific barriers—such as workflow issues, scheduling constraints, and awareness gaps—that prevented more families from participating.

Despite these obstacles, the pilot demonstrated that opportunistic screening is feasible and can reach children who might otherwise miss the chance for early detection. Researchers identified strategies to improve future implementation, setting the stage for larger, more effective screening programs.

This pilot is an important first step toward making Type 1 diabetes screening more accessible. By embedding screening into routine pediatric visits, researchers hope to identify more children at risk before symptoms develop.

The study underscores that screening for Type 1 diabetes remains uncommon in primary care, despite evidence that early detection can improve outcomes. Future programs will need to address the real-world barriers identified in this pilot to make screening truly routine for families who want it.

Source: Diabetes, obesity, and cardiometabolic CARE. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.